Eric Walker added CARB-X awards $3.2M to Trellis Bioscience for superbug disrupter - Homeland Preparedness News to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added Techulon awarded funding to develop antimicrobial to kill drug-resistant bacteria - Homeland Preparedness News to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added Oxford Drug Design wins UK-China antimicrobial resistance grant - Pharmafield to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added New class of antibiotics apparently also works against multi-resistant germs - Innovation Origins to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added Fighting antimicrobial resistance requires new diagnostic tools - STAT to Pharmaceutical makers, antibiotic resistance and the development of new drugs and Rapid testing, diagnostics and identification of cause of infection

Eric Walker added Firms to work together on superbugs in China to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added Business of Health Care - New Antibiotics | KWBU to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added Panel: Onus to Stop Abx Overuse Is on Prescribers | Medpage Today to a number of topics

Eric Walker added EFPIA responds to EC President-elect prioritization of antimicrobial r to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added Fluoroquinolone Antibiotics Pose a Huge Health Risk. Why Are Doctors Still Prescribing Them? to Pharmaceutical makers, antibiotic resistance and the development of new drugs, Fluoroquinolones and Antimicrobial stewardship

Eric Walker added Why India's Pharma Industry Needs to Act Now to Win Back the Trust It Lost to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added As Threat of Antibiotic Resistance Mounts, Biotechs Are Running Out of Cash and Time to a number of topics

Eric Walker added Recce Pharmaceuticals Ltd to benefit from $5 million in government funds for AMR Research Hub to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added Biopharm firm tackling antibiotic resistance closes funding round - The Scotsman to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added Acurx Successfully Completes Ph1 Clinical Trial for ACX-362E in CDI to Pharmaceutical makers, antibiotic resistance and the development of new drugs and ACX-362E

Eric Walker added Novel Probiotic Strain Dramatically Reduces Antibiotic Resistance In Infants | BioSpace to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added Novel Probiotic Strain Dramatically Reduces Antibiotic Resistance In Infants to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added Next-gen antibiotic research funded | Mirage News to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added Carb-X to Expand Funding of Specific Diagnostics to Support the Development of a Rapid Antibiotic Susceptibility Test to Treat Life-Threatening Blood Infections to Pharmaceutical makers, antibiotic resistance and the development of new drugs and CARB-X

Eric Walker added RedHill And Talicia In H. Pylori: The PDUFA Countdown - RedHill Biopharma Ltd. (NASDAQ:RDHL) | Seeking Alpha to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added Basilea announces positive results of phase 3 TARGET study with antibiotic ceftobiprole in the treatment of acute bacterial skin and skin structure infections (ABSSSI) | Small Molecules | News Channels to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added Basilea Pharma's Antibiotic Shows Non-inferiority in Late-Stage Trial | BioSpace to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added Schenectady biotech researcher wins $3M grant to fight E. coli | The Daily Gazette to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added The ID Pipeline: FDA Activity From the Week of July 28, 2019 to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added Harrow Health Forms Stowe Pharmaceuticals Subsidiary to Develop Broad Spectrum Anti-Microbial Ophthalmic and Otic Therapeutics to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added Prokaryotics Receives $2.3 Million SBIR Award Supporting Its Immune Potentiation Program and Advances Two Additional SBIR-funded Antibiotic Programs into Phase 2 Lead Optimization to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added New IMI project 'GNA Now' kicks off its battle against antimicrobial resistance | BioSpace to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added Novo Holdings invests over $10m in companies developing new antibiotics - EPM Magazine to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added Curza Announces $5.25 Million Investment - Utah Business to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added Curza Announces $5.25 million Investment from the Novo Holdings REPAIR Impact Fund to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added Novo Holdings REPAIR Impact Fund Invests USD 10 Million in Curza and Spero to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added Stewardship / Resistance Scan for Jul 17, 2019 | CIDRAP to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added Spero Therapeutics Announces $5.9 Million Award from U.S. Department of Defense to Further Clinical Development of SPR206 Nasdaq:SPRO to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added Antibiotic Resistance: Challenges and Opportunities for Treating Serious Bacterial Skin Infections to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added New FDA-Cleared Microbicidal Liquid Kills Deadly, Drug-Resistant Candida Auris Superbug on Contact to Pharmaceutical makers, antibiotic resistance and the development of new drugs and Multi-drug resistant Candida auris

Eric Walker added AiCuris and Lysando Join Forces in the Fight Against Antimicrobial Resistance to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added IDSA board member urges Congressional effort to stabilize antibiotic market, encourage new drugs - Homeland Preparedness News to Pharmaceutical makers, antibiotic resistance and the development of new drugs and Infectious disease (ID)

Eric Walker added Partnership in pursuit of new antibiotics class - European Biotechnology to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added Franco-German collaboration on novel antibiotics to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added Nosopharm and Evotec enter into collaboration to accelerate development of novel antibiotics | BioSpace to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added Study finds sizable delay in use of new antibiotics | CIDRAP to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added X-Biotix Therapeutics Joins Antimicrobials Working Group to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added Doctor’s day: Big bugs, big drugs, big bucks! to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added Entasis Therapeutics Announces New Results Supporting Advancement of Multiple Pathogen-Targeted Antimicrobial Programs at ASM Microbe 2019 | BioSpace to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added New Studies Highlight Activity of XERAVA™ Against Gram-Negative and Gram-Positive Clinical Isolates, Including Multidrug-Resistant Pathogens | BioSpace to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added New Studies Highlight Activity of XERAVA™ Against Gram-Negative and Gram-Positive Clinical Isolates, Including Multidrug-Resistant Pathogens | Business Wire to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added UK biotech receives over £8m to advance drug resistant antibiotics - EPM Magazine to Pharmaceutical makers, antibiotic resistance and the development of new drugs and CARB-X

Eric Walker added Oxford Drug Design receives over £8m in grant and equity investment | Cambridge Network to Pharmaceutical makers, antibiotic resistance and the development of new drugs

Eric Walker added Shionogi to Present Cefiderocol and COT-143 Data at American Society for Microbiology Microbe 2019 Meeting to Pharmaceutical makers, antibiotic resistance and the development of new drugs and Cefiderocol

Eric Walker added Spero Therapeutics to Present Data for All Pipeline Programs at the ASM Microbe 2019 Conference to Pharmaceutical makers, antibiotic resistance and the development of new drugs